Continuous Glucose Monitoring (CGM) offers a real-time, continuous view of your glucose levels, moving beyond periodic checks to provide a richer understanding of how your body processes sugars throughout the day and night. For many expecting parents navigating a gestational diabetes diagnosis, this technology can offer a sense of clarity and greater agency in managing their health.
What it is
CGM systems, like Dexcom or FreeStyle Libre, involve a small wearable sensor placed on your skin, typically on the back of your arm or abdomen. This sensor painlessly measures glucose levels in the interstitial fluid just beneath your skin, sending data wirelessly to a receiver or a smartphone app. Unlike traditional fingerstick tests, which give you a snapshot of your glucose at a single moment, CGM provides up to 288 readings per day. This continuous stream of information can reveal trends, patterns, and how different foods, activities, or even stress might impact your glucose levels.
While CGM has been used for some time in managing type 1 and type 2 diabetes, its application in pregnancy, especially for gestational diabetes, is an emerging area. Research, including the CONCEPTT trial (Lancet 2017) for type 1 diabetes, has shown improved birth outcomes with CGM use. For gestational diabetes, preliminary evidence is promising, suggesting that CGM can lead to better glucose control compared to relying solely on fingersticks in certain studies. It's about empowering you with more information to make informed decisions alongside your care team.

